The global decrease in cancer mortality: trends and disparities
D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri, D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri
Abstract
Background: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear.
Design: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate.
Results: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'.
Conclusions: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
Keywords: cancer; data collection/standards; global health; mortality; registries/standards; vital statistics.
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Source: PubMed
Upcoming Clinical Trials
-
Antalya City HospitalNot yet recruitingPain Management | Pericapsular Nerve Group Block (PENG Block) | Hip Arthroplasty, Total | Lateral Femoral Cutaneous Nerve Block | Quadro-Iliac Plane Block
-
Medipol UniversityNot yet recruiting
-
Balikesir UniversityNot yet recruitingLipedemaTurkey (Türkiye)
-
Aveta Biomics, Inc.Not yet recruitingHead and Neck Cancer | Oral Cavity Carcinoma | Oropharynx Squamous Cell Carcinoma | Oral Cavity | Oral Cavity Squamous Cell Carcinoma | Head and Neck (HNSCC) | Oropharyngeal
-
The University of Texas Health Science Center at...Trauma Research and Combat Casualty Care Collaborative (TRC4)RecruitingPost Traumatic Stress Disorder PTSDUnited States
-
Hoffmann-La RocheRecruitingMultiple SclerosisUnited Kingdom, United States, Mexico, Brazil
-
Fred Hutchinson Cancer CenterArcus Biosciences, Inc.; Bench to Bedside (B2B)Not yet recruitingMetastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Renal Pelvis Cancer AJCC v8 | Stage IV Ureter Cancer AJCC v8 | Unresectable Bladder Urothelial Carcinoma | Unresectable Renal Pelvis Urothelial Carcinoma | Unresectable... and other conditionsUnited States
-
Intrinsic TherapeuticsNot yet recruitingDisc Herniation | Lumbar Disc Herniation SurgeryUnited States
-
Imam Abdulrahman Bin Faisal UniversityNot yet recruiting
-
Gaziantep Islam Science and Technology UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruitingPostpartum Family Planning CounselingTurkey (Türkiye)
-
Rebecca Ahrens-NicklasNot yet recruitingUrea Cycle Disorders | Carbamoyl-Phosphate Synthase I DeficiencyUnited States
-
National Cancer Institute (NCI)Not yet recruitingHead and Neck Cancer | Nasopharyngeal Carcinoma | Hypopharyngeal Cancer | Adenoid Cystic Carcinoma | Prostate Cancer | Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Oral Squamous Cell Carcinoma | Salivary Gland Cancer | Paranasal Sinus Neoplasms | Metastatic Castration Resistant... and other conditionsUnited States